Form 8-K - Current report:
SEC Accession No. 0001493152-21-019840
Filing Date
2021-08-16
Accepted
2021-08-13 19:30:51
Documents
14
Period of Report
2021-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 70287
2 ex2-1.htm EX-2.1 149766
  Complete submission text file 0001493152-21-019840.txt   492200

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bcyp-20210812.xsd EX-101.SCH 4162
4 XBRL DEFINITION FILE bcyp-20210812_def.xml EX-101.DEF 28865
5 XBRL LABEL FILE bcyp-20210812_lab.xml EX-101.LAB 38663
6 XBRL PRESENTATION FILE bcyp-20210812_pre.xml EX-101.PRE 27476
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7192
Mailing Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140
Business Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140 (305) 204-3338
Big Cypress Acquisition Corp. (Filer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 211173939
SIC: 2836 Biological Products, (No Diagnostic Substances)